Sticky post

Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?

By Riya Gandhi ‘22 In recent years cancer therapy – especially cancer immunotherapy – has gained momentum and scientists’ interest has turned to immune checkpoint inhibitors (ICIs). ICIs aid in the suppression of checkpoint receptors to produce powerful immune responses against tumors. Although such a procedure is gaining momentum in clinical settings, much research must be done to legitimize this treatment for breast cancer. Under … Continue reading Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?

Sticky post

In Situ Administration of Cytokine Combinations Could Be the Future of Immunotherapy

By Riya Gandhi ‘22 Rather than look outwards for new cancer treatments, scientists are beginning to look inwards – that is, inside the human body – for advanced therapeutic treatments. Although the use of cytokines, biomolecules that direct an immune response,in cancer therapy has been attempted for decades, there is still room for much improvement. In a recent study on cytokines, researchers under the guidance … Continue reading In Situ Administration of Cytokine Combinations Could Be the Future of Immunotherapy

Cellular regulation of tumorigenesis

By Matthew Lee ‘21 Scientists and students alike are often well aware that one of the immune system’s most important roles is fighting cancer. In this effort, dendritic cells are especially important; particularly important are conventional type 1 dendritic cells (cDC1). Dendritic cells are a type of immune cell. cDCs can present tumor antigens to T cells and attract T cells via the secretion of … Continue reading Cellular regulation of tumorigenesis